Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology's ability to automate complex workflows and enhance productivity is seen as a ...

Moderna stock tumbled after the Senate Finance Committee voted to send RFK Jr.'s nomination for the HHS secretary to the full ...

A complainant shared four third-party posts on X (formerly Twitter) and two online articles with the PMCPA to make the case ...

Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

Moderna provided an update on the status of its trial investigating a vaccine candidate for norovirus in a company statement on Monday.

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats ...

Vaccines are a clinical product that is composed of live or dead material from an infectious agent – bacterium, virus, fungus or parasite – that elicit protective immunity against the pathogen ...

Shares of Moderna are trading higher Wednesday after Oracle Chairman Larry Ellison discussed the potential of artificial intelligence (AI) to revolutionize healthcare.

Last week, HHS under President Joe Biden awarded Moderna $590 million to help fast-track the development of an mRNA vaccine, the same technology used in some of the Covid vaccines. Whether to use ...

No cases of GBS have been reported to date associated with mResvia, the RSV vaccine from Moderna that was licensed in 2024; however, “vaccine safety monitoring programs are critical to gain more ...

Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu.